Prevalence of human T-Cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in South Chile

Journal of Medical Virology

Volumn 83, Issue 4, 2011, Pages 745-748

  Barrientos, Alejandro ^a   Lopez, Mauricio ^a   Sotomayor, Cristina ^a   Pilleux, Lilian ^a,b   Calderón, Susana ^a,b   Navarrete, Maritza ^b   Otth, Carola ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Medical School   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TAX PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHILE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHILE; FEMALE; HEMATOLOGIC NEOPLASMS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 79951527651     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22015     Document Type: Article

References (31)

1. Adedayo O, Shehu S. 2004. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in dominica: A seroprevalence study. Am J Hematol 77: 336-339.
2. Adedayo AO, Grell GAC, Bellot P. 2001. Fatal strongyloidiasis associated with human T-cell lymphotropic virus type-1 infection. Am J Trop Med Hyg 65: 650-651.
3. Araujo AC, Alfonso CR, Shor D, Andrada-Serpa MJ. 1993. Spastic paraparesis of obscure origin. A case-control study of HTLV-I positive and negative patients from Rio de Janeiro, Brazil. J Neurol Sci 116: 165-169.
4. Bartholomew C, Jack N, Edwards J, Charles W, Corbin D, Cleghorn FR, Blattner WA. 1998. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J Hum Virol 1: 302-305.
5. Cabrera ME, Marinov N, Guerra C, Morilla R, Matutes E. 2003. Chronic lymphoproliferative syndromes in Chile. A prospective study in 132 patients. Rev Med Chil 13: 291-298.
6. Cartier L, Cartier E. 1996. HTLV-I-II in Chile. In: Zaninovic V, editor. HTLV, Truths and Questions, Fund. Mar, Cali. pp. 150-158.
7. Cartier L, Mora C, Araya J, Castillo J, Verdugo R, Miller MA, Carleton-Gajdusek D, Gibbs CJ. 1989. HTLV-I positive spastic paraparesis in a temperate zone. Lancet 1: 556-557.
8. Cartier L, Araya F, Castillo JL, Verdugo R, Mora C, Gajdusek DC, Gibbs C. 1990. HTLV-I provirus in Chile, study of 140 neurological patients. Rev Med Chil 118: 622-628.
9. Cartier L, Ramirez E, Galeno H. 1999. Diagnosis of tropical spastic paraparesis by detection of Tax Gen of HTLV-I: A clinical study of 72 TSP/HAM patients. Rev Med Chil 127: 945-952.
10. del Guidice P. 1997. Scabies in HTLV-1 seropositive patients. J Am Acad Dermatol 36: 134-135.
11. Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, Silva EM, Reis AM, Catovsky D. 1997. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 15: 238-242.
12. Galeno H, Ramirez E, Mora J, Ojeda M, Cartier L. 1994. Anti HTLV-I antibody titers in seropositive infected individuals. Rev Med Chil 122: 1004-1007.
13. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Thé G. 1985. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 2: 407-410.
14. Hanrahan E, Madupu. 1994. Appleton & Lange's review of epidemiology & biostatistics for the USMLE by Appleton & Lange, Norwalk, Connecticut.
15. La Grenade H, Hanchard B, Fetcher V, Cranston B, Blattner W. 1990. Infective dermatitis of Jamaican children: A marker for HTLV-1 infection. Lancet 336: 1345-1347.
16. McNemar Q. 1947. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12: 153-157.
17. Miyagi J, Toda T, Uezato H, Ohshima K, Miyakuni T, Takasu N, Masuda M. 2002. Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan. Int J Hematol 75: 78-84.
18. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miy-ata M. 1992. HTLV-1 uveitis: A distinct clinical entity caused by HTLV-1. Jpn J Cancer Res 83: 236-239.
19. Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, Goedert JJ, Blattner WA. 1989. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with HTLV-1. Int J Cancer 43: 250-253.
20. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. 1989. Chronic inflammatory arthropathy associated with HTLV-1. Lancet 1: 441.
21. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. 1986. HTLV-I associated myelopathy: A new clinical entity. Lancet 1: 1031-1032.
22. Pereira J, Segurado A. 2009. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil. J Clin Virol 44: 185-189.
23. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
24. Pombo-de-Oliveira MS, Carvalho SM, Borducchi D, Dobbin J, Salvador J, Correa RB, Moellman A, Loureiro P, Chiattone C, Rios M. 2001. Adult T-cell leukemia/lymphoma and cluster of HTLV-I associated diseases in Brazilian settings. Leuk Lymphoma 42: 135-144.
25. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 6058-6068.
26. Ramirez E, Cartier L, Rios M, Fernandez J. 1998. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy. J Clin Microbiol 36: 1811-1813.
27. Ramirez E, Fernandez J, Cartier L, Villota C, Rios M. 2003. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients. Virus Res 91: 231-239.
28. Ramirez E, Cartier L, Flores R. 2004. In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-I, and PBMC from HAM/TSP patients and HTLV-I carriers. Arch Virol 149: 2307-2317.
29. Ramirez E, Cartier L, Torres M, Barria M. 2007. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients. J Med Virol 79: 782-790.
30. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S. 1994. Prevalence of serum and salivatory antibodies to HTLV-1 in Sjogren's syndrome. Lancet 344: 1116-1119.
31. Yoshida M, Miyoshi I, Hinuma Y. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035.